New details have emerged about how the healthcare industry has been trying to sway the debate in Congress. A study by the Sunlight Foundation and the Center for Responsive Politics has uncovered never-before-seen webs of campaign contributions from outside lobbyists and their clients to key members of Congress. Between January 2007 and June 2009, Max Baucus, the chair of the powerful Senate Finance Committee, collected contributions from thirty-seven outside lobbyists representing the pharmaceutical industry’s chief trade association, PhRMA, as well as thirty-six lobbyists who listed drug maker Amgen as their client. In all, eleven major health and insurance firms had their contributions to Baucus boosted through extra donations from ten or more of their outside lobbyists. Some thirty-two members of Congress got money from ten or more PhRMA lobbyists over the last two-and-a-half years. Amgen’s lobbyists did the same for twenty-four members.